Analyst Laurence Alexander of Jefferies maintained a Hold rating on Chemours Company (CC – Research Report), reducing the price target to $20.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Laurence Alexander has given his Hold rating due to a combination of factors influencing Chemours Company’s outlook. Despite the company’s Q4 EBITDA surpassing expectations, with figures $14 million above consensus estimates, potential challenges loom. The projected decline in Q1 EBITDA and the need for credit easing and Chinese stimulus to trigger a rebound in Advanced Performance Materials (APM) indicate cautious optimism.
Furthermore, while the decline in competitive pressure from China could boost TiO2 volumes in Europe and Opteon adoption may drive growth in Thermal & Specialized Solutions (TSS), these positives are counterbalanced by weak Freon sales and ongoing pressures in APM. Additional considerations, such as cost savings initiatives and restructuring costs due to the exit of the SPS Capstone business, contribute to a mixed forecast, justifying a Hold rating.
In another report released today, Morgan Stanley also maintained a Hold rating on the stock with a $22.00 price target.